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Adenylate kinases occur classically as cytoplasmic
and mitochondrial enzymes, but the expression of
seven adenylate kinases in the flagellated protozoan
parasite Trypanosoma brucei (order, Kinetoplastida;
family, Trypanosomatidae) easily exceeds the number
of isoforms previously observed within a single cell
and raises questions as to their location and function.
We show that a requirement to target adenylate kinase
into glycosomes, which are unique kinetoplastid-spe-
cific microbodies of the peroxisome class in which
many reactions of carbohydrate metabolism are com-
partmentalized, and two different flagellar structures
as well as cytoplasm and mitochondrion explains the
expansion of this gene family in trypanosomes. The
three isoforms that are selectively built into either the
flagellar axoneme or the extra-axonemal paraflagellar
rod, which is essential for motility, all contain long
N-terminal extensions. Biochemical analysis of the
only short form trypanosome adenylate kinase re-
vealed that this enzyme catalyzes phosphotransfer of
-phosphate from ATP to AMP, CMP, and UMP accep-
tors; its high activity and specificity toward CMP is
likely to reflect an adaptation to very low intracellular
cytidine nucleotide pools. Analysis of some of the phos-
photransfer network using RNA interference suggests
considerable complexity within the homeostasis of cel-
lular energetics. The anchoring of specific adenylate
kinases within two distinct flagellar structures pro-
vides a paradigm for metabolic organization and effi-
ciency in other flagellates.
The continuous production of ATP, its delivery from intra-
cellular sites of synthesis to sites of energy consumption, and
the homeostasis of adenine nucleotide pools are fundamental to
cellular viability. Adenylate kinase (ADK)1 and phosphagen
kinases, such as creatine kinase and arginine kinase, assume
pivotal roles in these fundamental processes (1). Phosphagen
kinases catalyze reversible phosphotransfer between ATP and
the guanidine acceptor (e.g. arginine or creatine), with the
phosphagen providing both a temporal and a spatial reserve of
high energy phosphate. ADK, on the other hand, catalyzes the
transfer of the -phosphate group from either ATP or GTP to
the phosphoryl acceptor AMP.
Disruption of the single copy ADK gene in Escherichia coli or
Schizosaccharomyces pombe is lethal (2, 3), but in Saccharo-
myces cerevisiae the ADK null phenotype reveals a compensat-
ing metabolic plasticity. S. cerevisiae survives because the
broad substrate specificity of its uridylate kinase (Ura6p) com-
pensates for the deficiency in cytoplasmic ADK activity (4).
However, a small proportion of the yeast ADK (Aky2p) is local-
ized in the mitochondrial intermembrane space (5), where it
may contribute to efficient translocation of ATP from the mi-
tochondrial matrix into the cytoplasm (1). Uridylate kinase is
not present in yeast mitochondria, and hence AKY2-deficient
S. cerevisiae exhibit a petite phenotype and are unable to grow
under nonfermentative conditions (6). In skeletal muscle of
transgenic AK1/ knock-out mice, metabolic reprogramming
and ultrastructural reorganization have been observed (7, 8).
Here, glycolytic flux, creatine kinase activity, and mitochon-
drial volume are increased to support muscle function, albeit
with reduced energy economy and efficiency under stress (7–9).
The focus of this study is the uniflagellate protozoan parasite
Trypanosoma brucei, the causal agent of human African sleep-
ing sickness (see, on the World Wide Web, www.who.int/tdr/
diseases/tryp/). There are many interesting and unusual as-
pects to trypanosome metabolism (10). A single aerobically
functioning mitochondrion and microbodies of the peroxisome
class are present. However, in the mammalian host, the mito-
chondrial energy metabolism of the parasite is largely re-
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pressed; neither cytochromes nor tricarboxylic acid cycle are
present. Glycolysis is the sole energy-generating pathway, and
pyruvate is excreted as the major end product of this glucose
catabolism. Uniquely, the first seven glycolytic enzymes occur
solely in peroxisomes. Peroxisomal targeting of glycolytic en-
zymes and certain other enzymes utilized for carbohydrate
metabolism (10) is characteristic of all trypanosomatids and
reflects the description of these trypanosomatid microbodies as
glycosomes (10, 11).
T. brucei is transmitted between mammalian hosts by its
insect vector (Glossina sp., tsetse fly). Procyclic trypanosomes
(found in the tsetse fly midgut) have an aerobic metabolism and
use a variety of carbon sources (12–14), and alternative oxidase
and cytochrome c oxidase constitute the two terminal enzymes
of an essential branched respiratory chain (14, 15). Although
oxidative phosphorylation is an important facet of procyclic
metabolism, pyruvate kinase and an acetate:succinate CoA-
transferase/succinyl-CoA synthetase cycle catalyze important
substrate phosphorylations. The cytoplasmic phosphotransfer
reaction catalyzed by the former enzyme appears to be essen-
tial, except perhaps under conditions where increased sub-
strate availability can result in increased mitochondrial amino
acid (proline) metabolism (12, 13, 16). Acetate:succinate CoA
transferase is restricted in its evolutionary distribution to
trypanosomatid mitochondria, anaerobic helminth mitochon-
dria, and protist hydrogenosomes; it catalyzes formation of
acetate from acetyl-CoA. This reaction, rather than entry into
the tricarboxylic acid cycle, is the predominant pathway used
for acetyl-CoA metabolism; acetate is excreted from the cell as
a major end product of metabolism, and the succinyl-CoA prod-
uct is recycled by mitochondrial succinyl-CoA synthetase, gen-
erating ATP (15). Deletion of acetate:succinate CoA-transfer-
ase initially results in a severe growth defect, before
compensatory metabolic rearrangements allow cells to adapt to
loss of the enzyme (17).
Here, we report that the complex stage-regulated metabo-
lism of T. brucei is buttressed by the expression of seven ADK-
like genes. The expression of seven ADKs within the context of
a single cell has not been reported previously, but in this
protozoan parasite it reflects the requirement to target ADK
into glycosomes and two distinct flagellar structures as well as
more classical intracellular sites such as cytoplasm and mito-
chondrion. Molecular interrogation of the ADK gene family,
while demonstrating metabolic adaptation, also indicates that
there is likely to be considerable complexity within the rela-
tionship between phosphotransfer activity and homeostasis of
cellular energetics.
MATERIALS AND METHODS
Reagents—All chemicals were purchased from Sigma unless other-
wise stated. Restriction enzymes and DNA-modifying enzymes were
purchased from Roche Applied Science.
Cells—Procyclic T. brucei, stock 427, was maintained at 27 °C in
SDM-79 medium supplemented with 10% (v/v) heat-inactivated fetal
calf serum as described previously (18). RNA interference (RNAi) ex-
periments were conducted using the procyclic 29-13 cell line, which has
been genetically modified in order to express the tetracycline repressor
protein and bacteriophage T7 RNA polymerase (19). Stable integration
of exogenous DNA into procyclic cells was carried out as described
previously (20). RNAi cell lines were maintained in the presence of the
selectable agents hygromycin (50 g/ml), G-418 (15 g/ml), and phleo-
mycin (3 g/ml) until 48 h prior to the start of an experiment. Extracts
from long slender and short stumpy bloodstream trypanosomes were
prepared and analyzed using antibody markers as described previously
(21). Cell counts were determined using either a Neubauer heamocy-
tometer (Sigma), or a CASY1 cell counter (Schärfe System).
Recombinant DNA Procedures—Genomic DNA was extracted as de-
scribed previously (22). RNA was obtained using a High Pure RNA
Isolation Kit (Roche Applied Science). Northern and Southern blotting
was carried out according to standard protocols (23); blots were washed
to high stringency (0.1 SSC (1 SSC: 0.15 M NaCl, 0.015 M sodium
citrate), 0.1% (w/v) SDS; 65 °C). Fluorescein-labeled DNA probes were
detected by enhanced chemiluminescence with CDP-star (Amersham
Biosciences). For two-step reverse transcription-PCR, cDNA was syn-
thesized using oligo(dT)15 primer and Omniscript (Qiagen). Incorpora-
tion of SyberGreen (Applied Biosystems) into relevant amplicons was
determined using an ABI Prism 7700 real time PCR system (Applied
Biosystems) and the following thermal cycling parameters: 95 °C, 10
min; 40 cycles of 95 °C, 15 s; 60 °C, 1 min. PCR products were analyzed
on gels to confirm the absence of nonspecific amplification. Controls
without reverse transcription and amplification using single primers
only were also carried out. DNA sequencing was performed using ABI-
Prism automated sequencing with custom-designed primers.
Plasmid Construction—Detailed descriptions of how the plasmids
used in this study were constructed are provided in the supplemental
information. RNAi plasmids were based on the opposing promoter sys-
tem pioneered by Englund and co-workers (20). For immunolocalization
of ADKA, ADKB, and ADKE, each containing a single Ty1 epitope at
their respective C termini, the plasmids pTAFADKA::Ty,
pTAFADKB::Ty, and pTubADKE::Ty were constructed. For the expres-
sion of the GFP::ADKD fusion protein, pVsg4GFP::ADKD was con-
structed. This fusion protein was expressed under the control of an RNA
polymerase I-transcribed EP1 promoter following stable integration of
pVsg4GFP::ADKD into a minichromosomal locus. For expression of
recombinant ADKG in E. coli, pTbAKGr was constructed.
Generation of ADKC/ Null Mutants—PCR amplification of hygro-
mycin and bleomycin resistance markers was achieved using primer
combinations ADKCko1 and ADKCko2 (template pGad8-tubulin (24))
or ADKCko3 and ADKCko4 (template pRM481 (25)), respectively (see
Supplemental Table I for primer sequences). The 5 region of each
primer contained 50 bp of homology to the ADKC locus, facilitating
gene disruption by homologous recombination; PCR products (3 g)
were used for transformation of procyclic 427 T. brucei. For second
round transformation of hygromycin-resistant ADKC/ heterozygotes,
the bleomycin resistance marker was amplified from a first round
heterozygote transformant using a primer combination of ADKCko5
and ADKCko6. The resulting PCR product was then used for stable
transformation of procyclic cultures. Integration events into trypano-
somes were analyzed by PCR and Southern mapping.
Expression and Analysis of Recombinant ADKG—Following trans-
formation of pTbAKGr into E. coli XL1-Blue (Stratagene), expression of
recombinant TbADKG was induced by the addition of isopropyl-D-thio-
galactopyranoside (60 g/ml). Recombinant protein was purified by
Ni2-nitrilotriacetic acid chromatography according to the manufactur-
er’s protocol (Qiagen). The activity of the recombinant enzyme was
measured as described previously by following the rate of NDP forma-
tion from NTP and NMP substrates in a coupled system that required
pyruvate kinase and lactate dehydrogenase (26). The standard reaction
mixture contained Tris-HCl (0.1 M, pH 7.6), KCl (80 mM), MgCl2 (1.4
mM), phosphoenolpyruvate (400 M), NADH (200 M), pyruvate kinase
(10 units/ml), lactate dehydrogenase (10 units/ml), NTP (0.8 mM), NMP
(2.3 mM), and recombinant ADKG (68.8 M). One unit of enzyme activ-
ity was defined as 1 mol of NAD formed/min.
Immunoblotting and Immunofluorescence—Polyclonal antiserum
against recombinant ADKG was prepared by Eurogentech. Polyclonal
rabbit antibodies raised against T. brucei aldolase were used as de-
scribed previously (27). SDS-PAGE and immunoblotting were carried
out according to standard methods (21). Immunofluorescence of form-
aldehyde- and methanol-fixed detergent-extracted cytoskeletons using
BB2 and ROD-1 (28) monoclonal antibodies was performed as described
previously (29, 30).
RESULTS
Seven ADK-like Genes Are Expressed in T. brucei—Using
NMPK genes characterized from S. cerevisiae, S. pombe, Homo
sapiens, E. coli, and Bacillus subtilis as query sequences, we
analyzed the T. brucei genome data bases at Sanger and the
Institute for Genome Research for the presence of NMPK
genes. We found open reading frames homologous to the gua-
nylate kinase and thymidylate kinase from S. cerevisiae and
humans (31–33), but no hits to cytidylate and uridylate kinase
gene families that are unique to bacteria (34–36) (data not
shown). We also found a T. brucei homologue of a very recently
discovered distinct class of ADK genes that is conserved in
eukaryotes and Archaea; in S. cerevisiae and humans, this
novel ADK family member is found in the nucleus (37). How-
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ever, through a combination of data base searching and PCR
cloning, we identified seven different sequences that shared
homology with the cytoplasmic and mitochondrial ADK genes
from yeast and humans (Fig. 1). Now that the T. brucei genome
project is nearing completion, all of the open reading frames
that we identified can now be viewed at the Sanger Centre Web
site (www.genedb.org/genedb/tryp/index.jsp). With the excep-
tion of the neighboring ADKC and ADKF, these genes are not
clustered in the genome. We also demonstrated that each of the
ADK genes was transcribed into mRNA using real time PCR to
monitor the incorporation of SyberGreen into specific ampli-
cons. This analysis revealed that each gene was expressed in
both procyclic and long slender bloodstream trypanosomes. We
hypothesized that the expression of seven different ADK genes
FIG. 1. Sequence alignment of seven adenylate kinases from T. brucei. Sequences were initially aligned in Clustal, and then the
alignment was adjusted manually. The asterisks and dots represent residues that are identical or conserved in a majority (six) of the sequences,
respectively. The characterized S. cerevisiae enzymes Aky2p (accession number M18455), Pak3p (accession number X65126), and Ura6p (accession
number M31455) were also included in the alignment. The highly conserved ATP-binding P-loop is boxed, and the length of the LID domain is
indicated by the dashed line. Other residues known to be important either in substrate binding or catalysis are highlighted by red and yellow
shading, respectively. The blue shading reveals two conserved hydrophobic residues that form part of the essential C-terminal amphipathic -helix,
which makes hydrophobic contact with the purine ring of ATP.
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in trypanosomes (more than has ever been observed previously
in any other unicellular organism or individual cell type) re-
flects a molecular radiation to fill particular metabolic niches.
Comparison of the trypanosome ADK family with homologues
from other organisms indicated that T. brucei ADKC and
ADKF possess no unusual or structurally distinctive charac-
teristics. In this regard, they resemble the cytoplasmic and
mitochondrial ADK isoforms of other eukaryotes. By contrast,
our attention was focused by unusual primary sequence char-
acteristics in each of the remaining five T. brucei enzymes.
The Short Form “Cryptic Kinase” Has Broad Substrate Spec-
ificity—TbADKG encodes the only trypanosome short form
ADK; the distinction between long and short ADK isoforms
referring to the length of the LID domain (38). The LID con-
tributes to the overall folding of NMPKs and changes confor-
mation following the binding of substrate to the enzyme. In
mammalian cells, the major cytoplasmic form of ADK is a short
form enzyme, and mitochondrial activity is associated with
longer ADK isoforms (38). In yeast, cytoplasmic and mitochon-
drial ADK activities are provided by long form ADK enzymes
(3, 39). Eukaryotic UMP/CMP kinases share primary sequence
homology with ADK and are always of the short kind (38).
Careful bioinformatic analysis places ADKG within the UMP/
CMP class of NMPK, yet an Asp residue that is predicted to be
very important in the discrimination between a CMP/UMP
versus an AMP substrate in UMP/CMP kinase (40) is substi-
tuted by a Gln residue (Gln100) in ADKG. This Gln residue is
conserved in the other T. brucei ADKs and the previously
characterized S. cerevisiae proteins Aky2p and Ura6p (Fig. 1),
indicating that in ADKG at least one of the residues considered
important for catalysis places ADKG with ATP:AMP phospho-
transferases rather than UMP/CMP kinases. Ura6p, on the
basis of its mutant phenotype, is a UMP/CMP kinase (41) but
the presence of Q111 may contribute to the broad specificity of
this enzyme and activity with an AMP substrate (42, 43). We
therefore investigated the substrate specificity of the cryptic
kinase, ADKG, in more detail.
ADKG was expressed in E. coli as a recombinant protein
with six His residues at its N terminus and purified using an
Ni2-nitrilotriacetic acid column. Following purification, a sin-
gle protein band of 24 kDa was visible on a Coomassie Blue-
stained SDS-polyacrylamide gel, in close agreement with the
predicted molecular mass of 23,793 Da for the recombinant
protein (data not shown). The activity of recombinant ADKG
with different substrates is shown in Table I. With regard to
the phosphate acceptor, ADKG was able to transfer phosphate
from ATP to CMP, AMP, and UMP but not to GMP or IMP. The
enzyme showed a 30-fold greater substrate preference for CMP
relative to UMP and exhibited substantial activity with AMP
(44% of that seen for CMP). Using AMP as the acceptor sub-
strate, ATP was found to be the preferred phosphate donor,
although some activity was also seen for other NTP substrates
(Table I). ADKG was also inhibited by diadenosine pentaphos-
phate (AP5A in Fig. 2), a transition state analogue that is a
specific inhibitor of ADKs but not other NMPKs (44). Km and
Vmax values were also calculated (Table II). These indicated
that CMP was a higher affinity substrate than AMP. On the
other hand, Vmax values showed that the enzyme reached sim-
ilar turnover rates with both AMP and CMP. However, maxi-
mum activity with CMP was reached at much lower substrate
concentration than with AMP. Immunoblot analysis using
polyclonal antibodies raised against recombinant enzyme indi-
cated that a protein band of 24 kDa was present in cell lysates
prepared from bloodstream and procyclic trypanosomes (data
not shown; gel loading 20 g of total cell protein from each
developmental stage). A lower amount of ADKG was found in
the cell cycle-arrested bloodstream stumpy forms (19% of the
level seen in long slender pleomorphic AnTat 1.1 bloodstream
forms; 28% of the level seen in procyclic trypanosomes) that are
preadapted for rapid differentiation into procyclic forms in the
tsetse fly midgut, indicating some degree of stage-specific reg-
ulation. The homogeneity of such parasite populations was
confirmed using antibodies against known stage-regulated pro-
teins, as described previously (21).
Building ADKs into Two Distinct Flagellar Structures—To
probe the subcellular localization of the three trypanosome
ADKs with unusually long leader sequences upstream of the
conserved P-loop, we engineered TbADKA, TbADKB, and
TbADKE to encode proteins that were tagged at their respec-
tive C termini with a single Ty epitope. Recombinant genes
were then integrated by homologous recombination into the
genome, and expression of the Ty-tagged proteins was deter-
mined by immunoblotting and immunofluorescence using the
anti-Ty BB2 antibody (29). Immunofluorescence images for
ADKA::Ty were reported previously (45) but are also shown
here for comparative purposes. On immunoblots a single cross-
reactive protein of the expected molecular mass (30 kDa) was
observed only in cell lines expressing a Ty epitope-tagged pro-
tein (data not shown). Immunofluorescence signals were also
observed only in cells expressing either ADKA::Ty, ADKB::Ty,
or ADKE::Ty but not in the untransfected parental cell line,
and this signal indicated that each protein was present in the
trypanosome flagellum. Importantly, flagellum-associated an-
tibody staining was retained in detergent-extracted trypano-
somes (Fig. 3, A–C), indicating that each protein was incorpo-
rated into a flagellar cytoskeletal structure. In Fig. 3, A and B,
the images shown are of cells double-labeled with the anti-tag
TABLE I












a The substrate concentrations were 2.3 mM NMP and 0.8 mM NTP.
b The specific activity of T. brucei ADKG with the substrate set of
AMP and ATP was 25.9 units/mg of protein and was taken as 100%.
FIG. 2. Inhibition of T. brucei adenylate kinase ADKG by
diadenosine pentaphosphate. Purified recombinant T. brucei
ADKG (0.3 M) was treated with the ADK inhibitor diadenosine
pentaphoshate (AP5A) for 5 min and then assayed for enzymatic
activity under standard conditions with 0.8 mM ATP and 2.3 mM
AMP. The ADKG activity is expressed as relative activity (percent-
age) to untreated control enzyme. Values represent the means of
three independent determinations.
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antibody BB2 and antibody ROD-1, which detects the
paraflagellar rod (PFR), an extra-axonemal structure that runs
alongside the classical “9  2” axoneme from the point where
the flagellum exits the flagellar pocket to its distal tip. Co-
localization of the BB2 and ROD-1 antibody patterns indicated,
therefore, that ADKA and ADKB are not associated with the
axoneme but rather with the PFR. On the other hand, BB2-
detected ADKE::Ty did not co-localize with ROD-1 antibody
(not shown), and the immunofluorescence extended to a posi-
tion close to the kinetoplast (Fig. 3C). The kinetoplast is phys-
ically attached to the flagellar basal body from which the ax-
oneme extends (46); our immunofluorescence data were
therefore consistent with the assembly of an ADK isoform
within the trypanosome axoneme. A spectrophotometric en-
zyme assay confirmed the presence of ADK activity in both
cytoskeletal fractions and purified flagella (45).
Identification of the Glycosomal ADK—In trypanosomes,
ADK activity has been found in purified glycosomes (47–49).
The evolutionary connectivity of glycosomes and peroxisomes
extends to the conservation of targeting and import mecha-
nisms between both organelles (11). Two canonical recognition
signals for the import machinery are a peroxisome targeting
signal 1, which is a C-terminal tripeptide motif (typically
-SKL), or a peroxisome targeting signal 2, which is a nonapep-
tide sequence (consensus -(R/K)(L/V/I)X5(H/Q)(L/A/F)) at the
N-terminal region of the targeted protein. An additional fea-
ture of many glycosomal matrix proteins is a high pI. The only
gene that we considered likely to encode a glycosomal ADK was
ADKD; the predicted protein contains a C-terminal -SKL motif
and exhibits a pI of 10.1. We demonstrated the glycosomal
localization of ADKD through the expression of ADKD, fused at
its N terminus to green fluorescent protein (GFP), and co-
localization of GFP fluorescence with the glycosomal marker
aldolase (Fig. 3D).
ADKD and ADKF Are Important for Growth—We used a
tetracycline-inducible RNAi system to investigate the conse-
quences of rapidly silencing the expression of each ADK gene in
the absence of the longer selective pressure that gene disrup-
tion approaches require. Thus, we tracked for up to 14 days
post-induction the growth of cell lines in which mRNA for
either ADKA, ADKB, ADKC, ADKD, ADKE, ADKF, ADKG, or
ADKA and ADKB was specifically targeted for destruction by a
double-stranded RNA-mediated decay process. By comparison
with the growth rates of noninduced controls, reduced growth
was seen only in the case of ADKD and ADKF knockdowns (Fig.
4). Ultrastructural analysis using electron microscopy indi-
cated that the slow growth phenotype resulting from RNAi
against the glycosomal ADK was not accompanied by any ob-
vious change in glycosome morphology or number (data not
shown).
Western blot analysis of RNAi cell lines for ADKG, encoding
a presumably essential UMP/CMP kinase activity, indicated in
at least one instance that the absence of phenotype may result
from obtaining only a moderate knockdown of protein levels
(Supplemental Fig. 1). However, in other cell lines producing
no discernable phenotype, an assay of ADK activity in cytoskel-
FIG. 3. Localization of ADKA, ADKB, and ADKE to the trypano-
some flagellum and ADKD to glycosomes. A and B, detergent-
extracted cytoskeletons from cells expressing either ADKA (A) or ADKB
(B) proteins tagged at the C terminus with a single Ty epitope were
used in double-labeling immunofluorescence with the anti-Ty tag anti-
body BB2 (anti-Tag; green) and the ROD-1 antibody (anti-PFR; red),
which recognizes a minor component of the extra-axonemal paraflagel-
lar rod. 4,6-Diamidino-2-phenyindole-stained nuclei and mitochondrial
DNA (kinetoplast) are shown in blue (DAPI). C, immunofluorescence
with antibody BB2 of a detergent-extracted cytoskeleton from a cell that
was expressing ADKE tagged at the C terminus with a Ty epitope and
was also elongating a new flagellum (an asterisk marks the tip of this
new flagellum). A white arrowhead shows the position of one kineto-
plast, which is physically attached to a flagellar basal body, and the
yellow arrowhead indicates the start of an immunofluorescence signal
close to this structure. Control experiments using an unmarked procy-
clic cell line and immunofluorescence using only secondary antibodies
confirmed the authenticity of ADKA, ADKB, and ADKE in the trypano-
some flagellum. D, co-localization of a GFP::ADKD fusion protein with
the glycosomal marker aldolase in immunofluorescence using anti-
aldolase-specific antibodies. The merged fluorescence also includes the
phase-contrast image.
TABLE II






Vmax (units/mg) AMP/ATP 77
CMP/ATP 78
a For Km(ATP), the concentration of AMP was fixed at 2.3 mM.
b For Km(NMP), the concentration of ATP was fixed at 0.18 mM.
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etal fractions from the ADKA and ADKB double knockdown
revealed a 80% reduction in activity compared with cytoskel-
etons isolated from noninduced controls (45). Disruption of the
ADKC gene produced only very small changes in the doubling
time of the ADKC/ null mutant (ADKC/ 8.12 h versus
ADKC/ 7.97 h and ADKC/ 8.06 h).
Comparative Genomic Analysis of ADK Families in Trypano-
somatids—Exploiting the recent availability of nearly complete
genomic data bases for several trypanosomatid parasites, some
of which succeed in environments different from that encoun-
tered by T. brucei, we asked whether the large ADK gene
family identified in the latter species was a common feature of
trypanosomatid biology. The results of this survey are summa-
rized in Table III. Based on sequence identity and syntenic
conservation, we identified orthologues of TbADKB, ADKC,
ADKD, ADKF, and ADKG from the genomes of T. cruzi and
Leishmania major. Orthologues of TbADKE are also present in
T. cruzi, L. major, and Leishmania infantum, although intrigu-
ingly putative orthologues from both Leishmania species are
characterized by a series of short deletions (Fig. 5). We also
identified a putative ADK isoform that is conserved between
L. major and L. infantum but absent from the Trypanosoma
genome data bases. Targeting of two distinct ADK isoforms to
the PFR appears to be restricted to African trypanosome spe-
cies (T. brucei and Trypanosoma vivax).
DISCUSSION
Our characterization of the extended ADK gene family in T.
brucei provides insight into an additional layer of complexity to
our understanding of energy metabolism in this important pro-
tozoan parasite. Remarkably, the ADK family in trypanosomes is
the largest identified so far in any organism; at least seven
distinct ADKs are expressed by both bloodstream and procyclic
trypanosomes. An obvious question arises as to why the ADK
family of trypanosomes is so large. The sequence and distribution
within the genome of each ADK gene indicate that this gene
family has not arisen as a consequence of recent gene duplication
events. Insight into why seven distinct ADKs are needed comes
from the revelation that individual isoforms are required in the
many diverse cellular compartments that occur in trypanosomes,
including its flagellum and the unique glycosomes. A general
absence of introns within protein-coding genes, polycistronic
transcription, and a lack of regulation at the level of transcript
initiation (50) preclude the use of alternative splicing or alterna-
tive transcription start sites to generate the diversity of targeting
signals required to partition different products of a single ADK
gene between diverse cellular compartments. In other eukaryotic
microbes, the use of such molecular mechanisms to differentially
target enzymes has been documented (e.g. see Ref. 51). Our
attention was focused on those T. brucei ADKs with unusual
structural properties.
Substrate Specificity of ADKG—Sequence analysis of the
T. brucei ADKs indicated that six enzymes are of the so-called
long variety, whereas the seventh enzyme is a short form kinase.
Bioinformatic analysis placed this short form enzyme, ADKG,
with UMP/CMP kinases of other organisms, but our biochemical
analysis of recombinant ADKG revealed that the enzyme was
significantly more active using an AMP phosphate acceptor than
using UMP. However, it is not without precedent for UMP/CMP
kinases to show activity toward AMP; indeed, the yeast ortho-
logue Ura6p has been reported to be more active with an AMP
substrate than with CMP (42, 43). Strikingly, the activity of
ADKG with CMP is very high (2.5 times the activity seen with
AMP) and reaches its Vmax at low CMP concentration. We believe
this high activity is linked to the very low CTP/CDP pools de-
tected in T. brucei (52). The intracellular CTP pool size in
T. brucei is only 26 M, approximately 10 times lower than the
corresponding pool in mouse fibroblasts, and the low Km value of
ADKG toward CMP may be critical in maintaining CDP/CTP
homeostasis. The high catalytic efficiency of T. brucei ribonucle-
otide reductase for CDP reduction and its high affinity for the
CDP/UDP-specific effector dATP could also represent biochemi-
cal adaptations toward the low CTP pool (53). The broad sub-
strate specificity of ADKG, in particular its activity with AMP,
means that we cannot exclude a possibility that this NMPK is
multifunctional within the trypanosome cytoplasm.
ADKs and Cell Fitness—Slow growth phenotypes were evi-
dent following RNAi against TbADKF and TbADKD in procy-
clic trypanosomes, but failure to observe growth phenotypes
when the expression of other ADKs were subjected to RNAi
reflected an inability to completely ablate gene expression
FIG. 4. RNAi against either TbADKD or TbADKF slows growth. Growth curves are of cells transfected with either p2T7Ti{ADKD} (A) or
p2T7Ti{ADKF} (B) and incubated in the absence (closed squares, solid lines) or presence (closed circles, dashed lines) of tetracycline (1 g/ml).
Shown in the insets are Northern blots (10 g of RNA analyzed per sample) that reveal mRNA abundance for ADKD and ADKF, respectively, in
the absence () or presence () of tetracycline 24 h after the induction of RNAi. The arrows indicate the points at which cultures were subpassaged
to densities shown on each growth curve. Representative experiments using one from a pair of independently obtained stable transformants are
shown. Similar experiments carried out with cell lines induced for RNAi against other trypanosome ADK genes or simultaneous RNAi against
TbADKA and TbADKB revealed no significant change in the growth rate relative to the noninduced controls.
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(likely in the case of ADKG) and/or was suggestive of functional
redundancy in culture. Although the notion of metabolic redun-
dancy or flexibility is evident from various molecular interro-
gations of gene function in trypanosomes (e.g. see Refs. 12 and
15), the subtle metabolic restructuring that is observed in
transgenic AK1/ and ScCKmit//M-CK/ mice provides a
specific paradigm for complex compensatory phenotypes that
can arise following the loss of adenylate or creatine kinase
activity, respectively (7, 8, 54). Only when tissues were placed
under metabolic challenge was the importance of the ADK-
catalyzed reaction for muscle function and energetic efficiency
realized (7, 9, 55). The ability to observe a mutant phenotype is
obviously a consequence of the interrogation conditions; any
“no phenotype” statement can merely reflect an inability to
apply the correct interrogation conditions.
In the case of the African trypanosome, the niches within
which it has evolved (tsetse fly midgut and salivary glands,
mammalian bloodstream) are, at present, difficult to interro-
gate with experimentally tractable cultured parasites. For in-
stance, whereas a classical tricarboxylic acid cycle plays no role
in the energy generation of cultured parasites (56), it is not
known whether a complete cohort of tricarboxylic acid cycle
enzymes is necessary for energy generation at any point during
a natural life cycle (14). It is conceivable that maintenance of
ATP homeostasis at the lowest metabolic cost could be critical
for successful transmission of T. brucei through tsetse. In this
context, certain ADKs could therefore assume essential roles
that cannot be compensated by an increase in high energy
phosphoryl flux through other metabolic pathways. It is per-
haps pertinent to note that arginine kinase activity has also
been detected in procyclic extracts (57). Again, we have seen
that RNAi against T. brucei arginine kinase yields no discern-
able phenotype in culture, although neither arginine kinase
activity nor protein can be detected 96 h after induction
of RNAi.2
Slow growth of the ADKF RNAi knockdown indicates loss of
a compartmentalized phosphotransfer activity that is not com-
pensable, but we can only speculate as to the cellular role of
this isoform. Since we might expect the broad substrate speci-
ficity of ADKG to be sufficient, at least in culture, to compen-
sate for the loss of any additional cytoplasmic ADK activity, we
suggest that slow growth does not occur because of the loss of
cytoplasmic ADKF. On the other hand, mitochondrial energy
generation is critical for growth of procyclic T. brucei (12, 15),
and in yeast the available data indicate that export of ATP
generated in the mitochondrial matrix to the cytoplasm is
dependant upon a mitochondrial intermembrane space ADK
activity provided by Aky2p (4, 6). ADK activity has been de-
tected previously in T. brucei mitochondrial fractions (49). By
2 M. Ginger, C. Pereira, and K. Gull, unpublished results.
TABLE III
Distribution of adenylate kinase genes in different trypanosomatids
Gene Location or function in T. brucei Homologue in T. cruzi Homologue in L. major Homologue in T. vivaxa
ADKA Flagellar No No Yes
ADKB Flagellar Yes Yes Yes
ADKC NDb Yes Yes
ADKD Glycosomal Yes Yes
ADKE Flagellar Yes Yes Yes
ADKF ND Yes Yesc
ADKG UMP/CMP kinase Yes Yes
Other LmjF25.23702d
a Only the homologues of flagellar enzymes are highlighted.
b ND, not determined.
c By comparison with homologues in Trypanosoma, this protein contains deletions in two Leishmania species (Fig. 5).
d A homologue is also present in L. infantum but is absent from the Trypanosoma.
FIG. 5. Primary sequence alignment of ADKE homologues from T. brucei, L. major, and L. infantum highlights deletions within
the Leishmania proteins. Sequences were initially aligned in Clustal, and then the alignment was adjusted manually. The P-loop is boxed, and
the important structural and catalytic residues highlighted in Fig. 1 are shown as white letters on a black background. The asterisks and dots
represent residues that are identical or conserved in all three sequences.
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analogy with our understanding of yeast biochemistry, further
studies could indicate whether ADKF is required for export of
mitochondrial ATP in trypanosomes.
Phosphotransfer within the Flagellum—In the case of the
flagellar ADKs, their independent identification through a pro-
teomic analysis of the trypanosome flagellum (45)3 and the
detection of ADK activity in isolated flagella confirm the local-
ization data presented in this paper. Whereas ADK activity has
long been associated with purified eukaryotic flagella (e.g. see
Refs. 58 and 59), the identity of bona fide flagellar proteins
possessing ADK activity had not, until recently, been estab-
lished. The biological function(s) of such activity remains enig-
matic; ADK could contribute to the numerous signaling pro-
cesses that regulate the coordination of axonemal dynein
ATPases and flagellar beating, but equally ADK activity could
be required for energetic efficiency within the flagellar com-
partment. Our discovery of an axonemal T. brucei ADK extends
our previous identification of ADK in the PFR (45). A parsimo-
nious explanation of such intriguing differential targeting
within the flagellum is that ADK assumes a different role
depending upon the flagellar structure to which it is targeted.
Integration or positioning within the close proximity of dy-
nein arms is an obvious possibility for any flagellar ADK, and
indeed an ODA5-dependant association of ADK with outer
dynein arms in Chlamydomonas reinhardtii was recently re-
ported (60). Intriguingly, however, a survey of the literature
indicates that the availability of a flagellar energy-generating
pathway may be conserved within flagellates and that the
identity of this energy-generating pathway may be determined,
at least in part, by the environment in which the flagellum
beats. For instance, upon release into sea water, sea urchin
spermatozoa derive energy for motility solely from mitochon-
drial fatty acid oxidation and oxidative phosphorylation; ATP is
propagated along the axoneme to the dynein ATPases by a
creatine kinase-catalyzed phosphocreatine shuttle (61, 62). On
the other hand, within the microaerobic environment of the
female reproductive tract, mammalian spermatozoa derive
chemical energy from a glycolytic pathway that is compartmen-
talized through the tethering of hexokinase and glyceralde-
hyde-3-phosphate dehydrogenase to the fibrous sheath that
surrounds the axoneme and outer dense fibers along the prin-
cipal piece of the sperm tail (63). It is true that sperm are
highly polarized cells containing little cytoplasm and perhaps a
limited capacity for diffusional exchange of metabolites, but
even in the case of a microbial flagellum, the recent character-
ization of a central pair multiprotein complex containing ADK
and enolase subunits highlights the probability of a scaffold for
assembly of an energy metabolism within Chlamydomonas
flagella also (64). In trypanosomes, the first six or seven en-
zymes of glycolysis are compartmentalized within glycosomes,
although we suggest that there is a theoretical possibility that
cytoplasmic phosphoglycerate kinase- and pyruvate kinase-cat-
alyzed phosphotransfer could also partition into the flagellum
of procyclic trypanosomes. However, during tsetse transmis-
sion, glucose is considered to provide a relatively scarce nutri-
ent, with demand for ATP satisfied through the mitochondrial
metabolism of amino acid substrates. In this context, the dis-
tribution of two ADKs along the length of the PFR could there-
fore be required to maintain energy economy in much the same
way as ADK maintains an essential energy economy in mouse
muscle (7, 9). Are trypanosome flagellar ADKs perhaps repre-
sentative of a more widespread cytoskeletal anchoring of met-
abolic pathways to maximize energetic efficiency in eukaryotic
parasites? Interesting case studies would be flagellate protozoa
Giardia and Trichomonas; both lack the capacity for oxidative
phosphorylation and can rely only on substrate level phospho-
rylations to generate ATP.
Finally, there is the issue of how ADKs with similar N-
terminal extensions are differentially targeted to either axon-
eme or PFR. We recently demonstrated that PFR targeting of
ADKA requires its N-terminal extension (45). Although this
N-terminal extension is also sufficient to confer flagellar tar-
geting of GFP, it cannot facilitate detergent- or salt-resistant
incorporation of GFP into PFR or axoneme. Anchoring of the
ADKs within the trypanosome cytoskeletal architecture there-
fore requires additional structural elements, and it may be that
such features also identify key interacting partners within
either axoneme or PFR, respectively.
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